Close Menu

NEW YORK (360Dx) – Chembio Diagnostics today said that the Brazilian health regulatory agency Agência Nacional de Vigilância Sanitária (ANVISA) approved the commercial use of the firm's DPP Micro Reader in that country, in collaboration with Bio-Manguinhos.

Chembio noted that because of the approval, its DPP Zika System, which includes a Zika IgM/IgG assay along with the micro reader, is also cleared for commercial use in Brazil.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
19
Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.